Clinical Trials Directory

Trials / Unknown

UnknownNCT05913791

Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema

Impact of Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
National University of Singapore · Academic / Other
Sex
All
Age
21 Years – 59 Years
Healthy volunteers
Not accepted

Summary

The study aims to assess the effects of daily consumption of nutrients-fortified eggs on eczema condition in individuals with eczema. It is hypothesised that daily consumption of nutrients-fortified egg, which is rich in antioxidants, will improve eczema conditions in individuals with eczema as compared to consumption of regular eggs.

Detailed description

Eczema refers to a group of conditions that induces inflammation of the skin. Of which, atopic dermatitis is the most common type. Eczema is common in children, and can continue to adulthood. Eczema is a chronic condition with no known cure. Anti-inflammatory agents have been shown to protect against atopic dermatitis. Vitamin D, E and polyunsaturated fatty acids are known to confer excellent anti-inflammatory benefits. This is a double-blinded, randomized, parallel study and all subjects will complete a 12-week study period. The study was designed based on previous research which reported that omega-3 supplementation significantly decreased blood IgE concentration (-29.0 ± 11.1, mean ± SD) compared to placebo supplementation (-7.7 ± 14.6, mean ± SD).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNutrients-fortified eggConsumption of 2 cooked nutrients fortified eggs (half-boiled, hard-boiled, or steamed)
OTHERRegular eggConsumption of 2 regular eggs, prepared in the same manner as nutrients-fortified egg, which serves as a placebo comparison.

Timeline

Start date
2023-03-06
Primary completion
2023-07-31
Completion
2025-01-01
First posted
2023-06-22
Last updated
2023-11-09

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT05913791. Inclusion in this directory is not an endorsement.